Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
ESMO: AZ, Hutchmed’s Orpathys combo shows post-Tagrisso power
With the second-line win and a positive first-line readout from a China study, AZ will speak with the FDA about its first-line regulatory strategy.
Angus Liu
Oct 25, 2026 11:30am
Akeso CEO looks for more ivonescimab combos after AZ deal
Oct 25, 2026 11:30am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Merck’s sac-TMT posts major PFS benefit in PD-L1-negative NSCLC
Oct 25, 2026 5:15am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
ESMO: Amgen’s Imdelltra stages Rasonque-like moment in SCLC
Oct 24, 2026 10:30am
